The Estée Lauder Companies Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EL research report →
Range $86 – $120
Price Chart
About the company
The Estée Lauder Companies Inc. is a global entity dedicated to the development, marketing, and sale of a diverse range of premium beauty and personal care items worldwide. Its extensive product catalog encompasses numerous offerings across four primary categories.
- CEO
- Stephane de la Faverie
- IPO
- 1995
- Employees
- 41,800
- HQ
- New York City, NY, US
AI snapshot
Six angles, distilled from the data.
EL is still in a multi-month recovery regime, trading above both the 50-day and 200-day moving averages. The stock remains well below its 52-week high, so the setup is constructive but not fully repaired after a large prior drawdown.
Street sentiment is cautious-to-positive: consensus sits at Hold, but the average target of $102.27 is above the current share price. Recent revisions skew upward, with multiple firms lifting targets into the $97-$120 range and CICC upgrading to Outperform.
The earnings profile has been strong, with EL beating EPS in 7 of the last 7 reported quarters. Next quarter consensus calls for $0.51 EPS, so shareholders should watch whether the company can keep the beat streak alive while sustaining the recent rebound in estimates.
No discretionary insider buying or selling stands out. The recent filings are award grants to directors and 10% owners, which are routine compensation-related flows rather than a directional signal.
Profitability is modest but stable: gross margin is 75.5% and operating margin is 7.0%, while revenue grew 6.3% year over year. Cash generation is solid at $2.23 billion of free cash flow, but leverage remains elevated with $9.25 billion of debt against $3.50 billion of cash.
EL’s brand portfolio and global distribution give it a premium position in personal care, especially in prestige skin care and fragrance. Valuation is still rich versus staples peers at 44.65x earnings, so the market is paying for a recovery rather than steady-state results.
Similar companies
Peers in the same neighborhood.
- Market Cap
- $34.17B
- P/E
- 185.24
- Fwd P/E
- 28.46
- PEG
- 0.71
- P/S
- 2.27
- P/B
- 9.01
- EV/EBITDA
- 24.24
- Div Yield
- 1.48%
- Gross Margin
- 75.50%
- Op Margin
- 11.14%
- Net Margin
- 1.21%
- ROE
- 4.63%
- ROIC
- 4.09%
Latest fiscal year · YoY change
- Revenue
- $15.05B+5.0%
- Gross Profit
- $11.36B+7.2%
- Op Income
- $1.68B
- Net Income
- $182.00M+116.1%
- EPS
- $0.50+115.9%
- OCF Growth
- +39.4%
- FCF Growth
- +96.4%
- 52W High
- $121.64
- 52W Low
- $66.22
- 50D MA
- $92.67
- 200D MA
- $92.39
- Beta
- 1.27
- RSI (14)
- 46
- Avg Volume
- 2.99M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Estée Lauder returned to growth in fiscal 2026, with sales, margins, and EPS improving meaningfully and management raising fiscal 2027 profitability guidance.· August 19, 2026
- Fiscal 2026 organic sales rose 3% and reported sales rose 5%, with positive sales performance in every quarter.
- Gross margin expanded 150 basis points for the full year to 75.5% in Q4/FY26, while operating margin expanded 320 basis points to 11.2%.
- Diluted EPS increased 66% to $2.51 for the full year, and Q4 diluted EPS was $0.39 versus $0.09 a year ago.
- Management raised fiscal 2027 operating margin guidance to 12.7% to 13.5% and expects organic sales growth of 3% to 5%.
- Growth was broadening across brands, regions, and channels, with China, travel retail, online, and North America all showing improvement.
Fiscal 2026 reported sales rose 5% and organic sales grew 3%. Full-year gross margin was 75.5%, up 150 basis points, and operating margin was 11.2%, up 320 basis points. Diluted EPS increased 66% to $2.51 for the full year, while Q4 EPS was $0.39 versus $0.09 last year. Net cash flows from operations were $1.8 billion, up from $1.3 billion, cash on hand ended at $3.5 billion, and CapEx was $457 million versus $602 million last year. For fiscal 2027, management expects organic sales growth of 3% to 5%, operating margin of 12.7% to 13.5%, an effective tax rate of approximately 33% to 34%, EPS of $3.10 to $3.35, operating cash flow of $1.3 billion to $1.4 billion, and CapEx of about 4% of sales. They also said the first half of fiscal 2027 should grow faster than the second half, and the Middle East conflict is not expected to be material to fiscal 2027 results based on current information.
Stephane de la Faverie struck an upbeat tone and framed fiscal 2026 as proof that Beauty Reimagined is working. He emphasized that the company is becoming more consumer-centric, faster, and more disciplined, and said the focus now is on accelerating the core business rather than transformational M&A. He highlighted broader growth across brands and geographies, stronger innovation, and greater operating leverage from a slimmer organization.
Akhil Shrivastava focused on the financial execution behind the turnaround: gross margin reached 75.5%, operating margin reached 11.2%, and operating cash flow rose to $1.8 billion despite higher restructuring payments. He said PRGP approvals were completed as of June 30, with $823 million of cumulative fiscal 2026 charges, and noted CapEx fell to $457 million as the company prioritized consumer-facing investments. For fiscal 2027, he raised the margin outlook to 12.7% to 13.5%, guided to EPS of $3.10 to $3.35, and said most restructuring cash payments will be behind the company after fiscal 2027, while deleveraging remains a cash priority.
Analysts pressed on whether the higher fiscal 2027 margin guide implies more upside from PRGP and SG&A savings; management said the beat in fiscal 2026, continued nonconsumer-facing optimization, and PRGP run-rate benefits support the higher outlook, with more of the full benefit showing in 2028. Questions also focused on why sales guidance of 3% to 5% is described as acceleration; management said the midpoint and top end represent acceleration versus fiscal 2026, driven by a stronger first-half innovation pipeline and faster North America growth. Several questions challenged travel retail volatility and China inventory management, and management responded that inventories are aligned to demand, travel retail has returned to positive growth recently, and China/travel retail are managed through a coordinated ecosystem with localized launches and channel coordination.
The bull case from this call is that Estée Lauder appears to have stabilized the business and is now seeing broad-based growth across brands, categories, regions, and channels. Management also believes the profit recovery is still early, with more SG&A and PRGP savings to come through over the next year and into 2028.
The main bear case is that management is still leaning on travel retail, China, and shipment timing to some degree, and they acknowledged that sales growth in the first half should be stronger than in the second half. They also said profitability is still concentrated in Skin Care and Asia, with more work needed to improve Makeup, Fragrance, Hair Care, and the Americas, and they noted ongoing restructuring cash needs and debt paydown priorities.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 99.5%
- Shares Outstanding
- 361.67M
- Float Shares
- 359.94M
of shares held by institutions
906 13F filers
Buy/sell ratio 3.42. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for EL, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| John BoozmanSenate · AR | Buy | Jul 2, 26 | Filing → |
| Kevin HernHouse · OK01 | Sell | Aug 5, 26 | Filing → |
| Michael T. McCaulHouse · TX10 | Buy | Apr 1, 26 | Filing → |
| Michael T. McCaulHouse · TX10 | Buy | Apr 9, 26 | Filing → |
| Michael T. McCaulHouse · TX10 | Buy | Apr 8, 26 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Jan 29, 26 | Filing → |
| Michael T. McCaulHouse · TX10 | Sell | Sep 30, 25 | Filing → |
| Daniel Milton NewhouseHouse · WA04 | Sell | Apr 11, 25 | Filing → |
| Sheldon WhitehouseSenate · RI | Sell | Apr 29, 25 | Filing → |
| Sheldon WhitehouseSenate · RI | Sell | Apr 29, 25 | Filing → |
| Michael T. McCaulHouse · TX10 | Buy | Mar 5, 25 | Filing → |
| Michael T. McCaulHouse · TX10 | Buy | Mar 4, 25 | Filing → |
| Julie JohnsonHouse · TX32 | Sell | Feb 12, 25 | Filing → |
| Julie JohnsonHouse · TX32 | Buy | Jan 15, 25 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 27.95M | ▲ 1.04M |
| Bank Of America Corp | 21.25M | ▲ 7.41M |
| Blackrock, Inc. | 20.83M | ▲ 2.28M |
| Vanguard Capital Management LLC | 16.16M | ▲ 82.54K |
| Vanguard Portfolio Management LLC | 12.38M | ▲ 237.49K |
| State Street Corp | 11.54M | ▼ 250.69K |
| Fmr LLC | 10.65M | ▼ 7.47M |
| Eagle Capital Management LLC | 9.01M | ▲ 1.08M |
| Geode Capital Management, LLC | 6.66M | ▲ 8.54K |
| Invesco Ltd. | 5.86M | ▲ 649.56K |
| Bank Of New York Mellon Corp | 5.82M | ▼ 973.59K |
| Independent Franchise Partners Llp | 4.94M | ▼ 1.69M |
Held by 1,732 ETFs
Biggest fund positions in EL by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 15, 26 | Tejada Jennifer | other | 16.03 |
| Sep 15, 26 | Strong Dana | other | 2.88 |
| Sep 15, 26 | Nunez Arturo | other | 15.56 |
| Sep 15, 26 | ZANNINO RICHARD F | other | 38.9 |
| Sep 15, 26 | ZANNINO RICHARD F | other | 10.89 |
| Sep 15, 26 | Lauder William P | other | 2.88 |
| Sep 15, 26 | LAUDER GARY M | other | 16.1 |
| Sep 15, 26 | LAUDER JANE | other | 2.88 |
| Sep 15, 26 | STERNLICHT BARRY S | other | 174.27 |
| Sep 15, 26 | STERNLICHT BARRY S | other | 68.05 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our EL coverage
Recent articles, reports, and earnings notes.

Estée Lauder (EL): Turnaround Gains, But Valuation Is Tight
Estée Lauder is back to growth with improving margins, but the stock already prices in much of the recovery. The report lands on a Hold as Skin Care and Fragrance offset weakness in Makeup and Hair Care.

The Estée Lauder Companies Inc. (EL) jumps on deep earnings
The Estée Lauder Companies Inc. (EL) jumped after a solid earnings beat, but the real story is deeper: returning organic growth, margin expansion, stronger cash flow and improving regional/category mix. This analysis examines whether the recovery can support a lasting rerating beyond the headline pop.

The Estée Lauder Companies Inc. (EL) jumps on earnings beats
The Estée Lauder Companies Inc. (EL) jumps 16.3% after reporting earnings beats, as investors react positively to stronger-than-expected results and improved outlook.
Want a deeper read on EL?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
EL CIERRE — 25 DE SEPTIEMBRE
youtube.com · Sep 25
The Estée Lauder Companies and the Breast Cancer Research Foundation Launch Largest Global Research Initiative on Breast Cancer in Younger Women
businesswire.com · Sep 23
Paul Fribourg Sells 58,000 Shares of Estee Lauder Companies (NYSE:EL) Stock
defenseworld.net · Sep 17
Can Estee Lauder's Profound Partnership Strengthen AI Visibility?
zacks.com · Sep 16
Why Estee Lauder (EL) is a Top Momentum Stock for the Long-Term
zacks.com · Sep 16
The Estée Lauder Companies Announces Partnership with Profound to Expand AI Visibility Across Its Global Brand Portfolio
businesswire.com · Sep 14
The Estée Lauder Companies Inc. (EL) Presents at Barclays 19th Annual Global Consumer Staples Conference Transcript
seekingalpha.com · Sep 9
The Estée Lauder Companies Announces Expanded Roles for Brian Franz and Amber English
businesswire.com · Sep 8
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
AI analysis · Last refreshed September 22, 2026 · Live quote · Not investment advice